Education
About Us
Working with TipRanks
Follow Us
U.s. Physical Therapy (USPH)
NYSE:USPH
USPH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$62.77 - $108.14
Previous CloseN/A
Volume11.83K
Average Volume (3M)124.99K
Market Cap
$1.05B
Enterprise Value$1.86B
Total Cash (Recent Filing)$11.47M
Total Debt (Recent Filing)$12.11M
Price to Earnings (P/E)37.7
Beta0.81
Next Earnings
May 01, 2025EPS Estimate
0.44Last Dividend Ex-Date
Mar 14, 2025Dividend Yield2.55%
Share Statistics
EPS (TTM)1.84
Shares Outstanding15,191,689
10 Day Avg. Volume146,091
30 Day Avg. Volume124,988
Financial Highlights & Ratios
PEG Ratio1.01
Price to Book (P/B)N/A
Price to Sales (P/S)1.71
Price to Cash Flow (P/CF)12.50
P/FCF Ratio14.10
Enterprise Value/Market Cap1.77
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit15.03
Enterprise Value/Ebitda21.43
Forecast
1Y Price Target
$108.25Price Target Upside56.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
---
US Physical Therapy News
PremiumCompany Announcements
US Physical Therapy Approves New Executive Incentive Plans
PremiumCompany Announcements
US Physical Therapy Acquires Wyoming Clinics for Expansion
PremiumCompany Announcements
U.S. Physical Therapy Reports Strong 2024 ResultsPremiumCompany Announcements
U.S. Physical Therapy Reports Strong Growth Amid Challenges---
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe acquisition of Metro contributed significantly to revenue growth and expanded the number of clinics beyond expectations.
Dividend IncreaseThe board increased the quarterly dividend rate, reflecting confidence in the company's financial health and future prospects.
Revenue GrowthTotal revenue of $180 million grew 16.5% from the prior-year period and marked a modest 3% beat on the $175 million consensus; the top-line performance was driven primarily by solid core volume trends as demand remains strong.
Bears Say
Cost IncreaseManagement continues to contend with labor inflation, as salaries and related costs per visit increased significantly.
Earnings MissAdjusted EPS of $0.51 came in light versus the expectation of $0.56.
Earnings PressureManagement stated that the Medicare rate reduction for 2025 would likely negatively impact adjusted EBITDA by approximately $5.7 million.
---
Ownership Overview
1.55% Insiders
31.61% Mutual Funds
1.12% Other Institutional Investors
42.73% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
USPH FAQ
What was U.s. Physical Therapy’s price range in the past 12 months?
U.s. Physical Therapy lowest stock price was $62.77 and its highest was $108.14 in the past 12 months.
What is U.s. Physical Therapy’s market cap?
U.s. Physical Therapy’s market cap is $1.05B.
When is U.s. Physical Therapy’s upcoming earnings report date?
U.s. Physical Therapy’s upcoming earnings report date is May 01, 2025 which is in 17 days.
How were U.s. Physical Therapy’s earnings last quarter?
U.s. Physical Therapy released its earnings results on Feb 26, 2025. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.689 by -$0.179.
Is U.s. Physical Therapy overvalued?
According to Wall Street analysts U.s. Physical Therapy’s price is currently Undervalued.
Does U.s. Physical Therapy pay dividends?
U.s. Physical Therapy pays a Quarterly dividend of $0.449 which represents an annual dividend yield of 2.55%. See more information on U.s. Physical Therapy dividends here
What is U.s. Physical Therapy’s EPS estimate?
U.s. Physical Therapy’s EPS estimate is 0.44.
How many shares outstanding does U.s. Physical Therapy have?
U.s. Physical Therapy has 15,191,689 shares outstanding.
What happened to U.s. Physical Therapy’s price movement after its last earnings report?
U.s. Physical Therapy reported an EPS of $0.51 in its last earnings report, missing expectations of $0.689. Following the earnings report the stock price went down -6.043%.
Which hedge fund is a major shareholder of U.s. Physical Therapy?
Currently, no hedge funds are holding shares in USPH
---
US Physical Therapy Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$108.25 (56.09% Upside)
$108.25 (56.09% Upside)
Blogger Sentiment
Bearish
USPH Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 28.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $142.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.21%
12-Months-Change
Fundamentals
Return on Equity
5.75%
Trailing 12-Months
Asset Growth
17.38%
Trailing 12-Months
Company Description
U.s. Physical Therapy
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
---
USPH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong patient volume growth, successful acquisitions, and significant revenue increases. However, challenges in cost management and Medicare rate reductions presented notable headwinds. Overall, the company is optimistic about overcoming these challenges with strategic initiatives.Read More>---
USPH Stock 12 Month Forecast
Average Price Target
$108.25
▲(56.09% Upside)
Technical Analysis
AMN Healthcare Services
―
National Healthcare
―
Pennant Group
―
Aveanna Healthcare Holdings
―
Best Analysts Covering USPH
1 Year
1 Year Success Rate
16/33 ratings generated profit
1 Year Average Return
+1.02%
reiterated a buy rating 2 months ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 48.48% of your transactions generating a profit, with an average return of +1.02% per trade.
---